MedImmune, Inc. (Jobs) Says No To Suggested Sale; Intends To Implement Business Plan
LOS ANGELES, Feb 16 (Reuters) - MedImmune Inc. (MEDI.O: Quote, Profile, Research) has concluded that the best way to maximize value for shareholders is to aggressively implement its business plan, rather than pursue a sale of the company, the drugmaker said in a regulatory filing on Friday.